Business context and reporting period
Innovative Industrial Properties, Inc. (IIP) filed this Form 8-K for an event dated September 28, 2026; it was signed October 1, 2026. The filing reports an amendment to IIP’s mezzanine construction loan for Alewife Park, a life science campus in West Cambridge, Massachusetts. It does not report quarterly or annual operating results.
Transaction and key financial terms
- The amendment increases the loan’s maximum principal by $267.0 million, to $400.0 million. IIP’s wholly owned subsidiary may provide up to $245.0 million under Note B; the existing mezzanine lender may provide up to $22.0 million under Note C.
- IIP funded an initial advance of approximately $111.0 million. Proceeds repaid an $85.0 million bridge loan and covered accrued interest, fees, a minimum-return payment and other amounts, as well as transaction costs. Note C also funded an extension fee.
- Remaining amounts are available for debt service and costs; Note B may also fund specified tenant improvements, landlord work and campus improvements, subject to loan conditions, including budget and draw requirements and no defaults.
- The loan rate is the greater of 14% per year or the applicable benchmark rate (initially one-month Term SOFR) plus 9%. Interest is calculated using the combined mezzanine and senior mortgage balances, less interest paid on the senior mortgage.
- The mezzanine loan maturity is extended to February 9, 2028. A further one-year extension is available subject to conditions, including extension of the senior mortgage loan, whose maturity is currently February 2027, subject to its own terms.
Material changes and investor implications
- The amendment replaces the borrower’s $85.0 million bridge financing and expands the existing mezzanine facility to support Alewife Park construction and leasing-related work.
- The loan is secured by pledges of ownership interests in entities holding the property and benefits from completion, environmental and recourse guaranties from IQHQ, LP. It is generally nonrecourse to the borrower, subject to customary carve-outs and guaranties.
- IIP has specified consent rights over certain actions, including advances under Note B, and may purchase some or all of the existing mezzanine lender’s notes, subject to contractual and REIT-related conditions.
- IIP receives a right of first offer to purchase or finance/refinance Alewife Park, but that right becomes effective only when Note B funding reaches $155.0 million, subject to the agreement’s calculation and conditions. Until then, the lenders’ existing right of first negotiation remains in effect.
Outlook, risks and unusual items
The filing gives no company revenue, profit, cash flow, margin, debt, liquidity or dividend figures, and provides no financial guidance. It describes a sizable, staged loan commitment rather than a fully funded $245.0 million IIP investment. Future advances depend on contractual conditions; repayment and returns depend on the borrower’s ability to meet its obligations and on project execution. The intercreditor agreement limits certain mezzanine rights and subordinates some enforcement actions to senior lenders. The company cautions that forward-looking statements are subject to risks described in its SEC filings.
Important facts for investors to verify
- How much of Note B and Note C has been funded beyond the approximately $111.0 million initial advance, and what conditions remain for further draws?
- Whether the senior mortgage loan is extended beyond February 2027 and whether the borrower can satisfy the mezzanine loan’s extension conditions.
- Whether Note B funding reaches the $155.0 million threshold that activates IIP’s right of first offer.
- The borrower’s repayment capacity, Alewife Park construction and leasing progress, and any defaults or changes in collateral value.
- The full loan, co-lender, intercreditor and right-of-first-offer terms in the exhibits, including fees, minimum-return provisions and IIP’s consent rights.